NEW YORK–(BUSINESS WIRE)–AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECGTM software platform has been selected as winner of the “Best New Technology Solution for ECG” award in the 9th annual MedTech Breakthrough Awards. The program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, […]
Tag: AccurKardia
AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data
January 07, 2025 07:05 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its ECG-based, AI-powered AK+ Guard™ hyperkalemia detection software. The investigational technology uses Lead I ECG data […]
AccurKardia Announces Final Closing of $2.7 Million Series Seed Round
This investment will support AccurKardia’s mission to deliver world class clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. June 20, 2023 01:11 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–AccurKardia, Inc., a medical AI software company […]
AccurKardia and Mawi Announce Strategic Collaboration to Provide Automated ECG Analytics for the new Mawi Watch
The two leading innovative companies have announced a landmark agreement to equip Mawi’s new cardiac monitoring watch with AccurKardia’s automated ECG analytics NEW YORK & LONDON–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, announced today it will collaborate with Mawi, a medtech provider of medical […]
AccurKardia’s ‘AccurBeat’ Found to be Promising Alternative in QT/QTc Remote Monitoring According to Study by HITLAB and SUNY Downstate
New study published on JMIR Formative Research showcases clinical performance of AccurKardia’s AccurBeat platform for QT/QTc remote monitoring using smartwatch ECG data NEW YORK–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the clinical value of its AccurBeat platform. […]
AccurKardia joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
American Heart Association consortium advances development of evidence-based health tech solutions NEW YORK–(BUSINESS WIRE)–AccurKardia, a software company that provides device-agnostic and automated ECG analytics, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building and fostering health technology […]
AccurKardia Announces Collaboration with MDF Instruments to Develop ECG Solutions for the Next Generation of Stethoscopes
NEW YORK & RINCON, Puerto Rico–(BUSINESS WIRE)–AccurKardia, Inc., a software company that provides clinical-grade, device agnostic, automated ECG analytics, today announced a collaboration with MDF Instruments, a highly-regarded and longstanding medical supplier, to develop ECG (electrocardiogram) solutions for the next generation of stethoscopes. This collaboration brings together AccurKardia’s cutting edge innovation […]